Therapeutic Effect of Genistein-Stimulated Human Mesenchymal Stem Cells in Myocardial Infarction
Journal Title: Journal of Transplantation & Stem Cell Biology - Year 2014, Vol 1, Issue 1
Abstract
Stem cells offer significant therapeutic promise for the treatment of ischemic diseases. However, stem cells transplanted into ischemic tissue exhibit limited therapeutic efficacy because of poor engraftment in vivo. Several strategies aimed at improving the survival and engraftment of stem cells in ischemic myocardium have been developed, including cell transplantation in combination with growth factor delivery, genetic modification of stem cells, and cell therapy by using scaffolds. In this study, we examined the effects of genistein on therapeutic efficacy in an acute myocardial ischemia model. We found that treatment with genistein induced enhanced human mesenchymal stem cell (hMSC) proliferation. These responses were accompanied by increases in the phosphorylation of extracellular signal-regulated kinase (ERK)1/2 signaling. Blockade of each signal pathway abrogated the genistein-induced promotion of hMSC proliferation, suggesting that genistein affects both of these essential signaling pathways. Injection of genistein stimulate-hMSCs (geni + hMSCs) into myocardial ischemic sites in vivo induced cellular proliferation and survival of cells at the ischemic sites and thereby enhanced angiogenic cytokine secretion. These results show that genistein stimulate-hMSCs exhibits markedly enhanced anti-apoptotic capabilities compared to those exhibited by hMSCs alone; thus, they enhance the repair of ischemic myocardial injury through cell survival and angiogenic cytokine production.
Authors and Affiliations
Sang Hun Lee
Keywords
Related Articles
- EP ID EP207553
- DOI 10.13188/2374-9326.1000004
- Views 119
- Downloads 0
Scaffold Free 3D Culture of Mesenchymal Stem Cells; Implications for Regenerative Medicine
Mesenchymal stem cells (MSCs) are recognized as important sources for regenerative medicine (RM). Adherent cultures, long time considered definitory for MSCs phenotype, are relatively easy to perform and to assess. Two d...
Organ Bioengineering, Regeneration and Repair: Where the Future of Organ Transplantation is Taking Shape
Although organ transplantation is now widely viewed as one of the monumental achievements in the history of modern medicine, that was not always the case. Indeed, back at the beginning of the 20th century the idea of rep...
Stem Cell Therapies in Regenerative Medicine and Diabetes Mellitus: Advances, Constraints and Future Prospects
Stem cell therapy is one of the most promising treatments for the near future. This kind of therapy can ameliorate or even reverse some diseases and have potential applications in regenerative and replacement medicines a...
Therapeutic Effect of Genistein-Stimulated Human Mesenchymal Stem Cells in Myocardial Infarction
Stem cells offer significant therapeutic promise for the treatment of ischemic diseases. However, stem cells transplanted into ischemic tissue exhibit limited therapeutic efficacy because of poor engraftment in vivo. Sev...
First Results on Three Patients Treated with Topical Recombinant Human Erythropoietin (rhEPO) to Improve Wound Healing in Diabetic Foot Ulcers
Chronic wounds not only induce individual distress but also cause enormous and rapidly growing costs for our health care systems and society in general. The fastest growing groups of chronic wounds are Diabetic Foot Ulce...